Erythropoietin (EPO) Increases Myelin Gene Expression in CG4 Oligodendrocyte Cells through the Classical EPO Receptor

Abstract Erythropoietin (EPO) has protective effects in neurodegenerative and neuroinflammatory diseases, including in animal models of multiple sclerosis, where EPO decreases disease severity. EPO also promotes neurogenesis and is protective in models of toxic demyelination. In this study, we asked...

Celý popis

Podrobná bibliografie
Hlavní autoři: Ilaria Cervellini, Alexander Annenkov, Thomas Brenton, Yuti Chernajovsky, Pietro Ghezzi, Manuela Mengozzi
Médium: Článek
Jazyk:English
Vydáno: BMC 2013-06-01
Edice:Molecular Medicine
Témata:
On-line přístup:https://doi.org/10.2119/molmed.2013.00013